| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
2002
|
38 |
S1 |
p. S55-S56
2 p.
|
artikel
|
| 2 |
Bio- and chemoprevention
|
|
|
2002
|
38 |
S1 |
p. S42-S45
4 p.
|
artikel
|
| 3 |
Breast cancer
|
|
|
2002
|
38 |
S1 |
p. S45-S49
5 p.
|
artikel
|
| 4 |
Epidemiology — laboratory
|
|
|
2002
|
38 |
S1 |
p. S39-S42
4 p.
|
artikel
|
| 5 |
GI-cancer
|
|
|
2002
|
38 |
S1 |
p. S49-S53
5 p.
|
artikel
|
| 6 |
Late abstract
|
|
|
2002
|
38 |
S1 |
p. S53-
1 p.
|
artikel
|
| 7 |
Session 2 S3. Approaches to identify low penetrance cancer susceptibility genes using mouse models
|
de Koning, John P.
|
|
2002
|
38 |
S1 |
p. S5-
1 p.
|
artikel
|
| 8 |
Session 7 S20. Cancer chemoprevention: Strategies to save our skin
|
Einspahr, Janine G.
|
|
2002
|
38 |
S1 |
p. S23-
1 p.
|
artikel
|
| 9 |
Session 7 S22. Chemoprevention of lung cancer: New directions
|
Szabo, Eva
|
|
2002
|
38 |
S1 |
p. S25-
1 p.
|
artikel
|
| 10 |
Session 7 S21. Chemoprevention of non-melanoma skin cancer: Experience with a polyphenol from green tea
|
Linden, Kenneth
|
|
2002
|
38 |
S1 |
p. S24-
1 p.
|
artikel
|
| 11 |
Session 8 S25. Chemoprevention of prostate cancer: State of the art
|
Klein, Eric
|
|
2002
|
38 |
S1 |
p. S28-
1 p.
|
artikel
|
| 12 |
Session 9 S30. Development of chemoprevention clinical trials: Recent findings in the colon
|
Lipkin, Martin
|
|
2002
|
38 |
S1 |
p. S33-
1 p.
|
artikel
|
| 13 |
Session 9 S28. Epidemiology of colorectal cancer: Dietary and lifestyle interventions
|
Boyle, Peter
|
|
2002
|
38 |
S1 |
p. S31-
1 p.
|
artikel
|
| 14 |
Session 10 S31. Fecal Occult Blood (FOB) screening — trial evidence, practice and beyond
|
Rennert, Gad
|
|
2002
|
38 |
S1 |
p. S34-
1 p.
|
artikel
|
| 15 |
Session 4 S9. Genetically altered rodents and human tumor cells as preclinical models for prevention of intestinal cancers
|
Gerner, Eugene W.
|
|
2002
|
38 |
S1 |
p. S12-
1 p.
|
artikel
|
| 16 |
Session 9 S29. Genetic background of risk selection for chemoprevention studies and interventions in colorectal cancer
|
Müller, Hansjakob
|
|
2002
|
38 |
S1 |
p. S32-
1 p.
|
artikel
|
| 17 |
Session 2 S2. Genetic susceptibility and predicting cancer risk in individuals
|
Pharoah, Paul D.P.
|
|
2002
|
38 |
S1 |
p. S4-
1 p.
|
artikel
|
| 18 |
Session 5 S16. HRT opposed by tamoxifen (HOT study): Rationale and design
|
Decensi, Andrea
|
|
2002
|
38 |
S1 |
p. S19-
1 p.
|
artikel
|
| 19 |
Session 5 S14. IBIS-I and ATAC trials. Update and implications for IBIS-II
|
Cuzick, J.
|
|
2002
|
38 |
S1 |
p. S17-
1 p.
|
artikel
|
| 20 |
Session 3 S7. Identifying new breast cancer susceptibility genes
|
Easton, Douglas
|
|
2002
|
38 |
S1 |
p. S9-
1 p.
|
artikel
|
| 21 |
Session 5 S13. Impact of tamoxifen as a preventive agent in clinical practice and update of the STAR trial
|
Wickerham, D.L.
|
|
2002
|
38 |
S1 |
p. S16-
1 p.
|
artikel
|
| 22 |
Session 10 S32. Is FOB screening really the answer for lowering mortality in colorectal cancer?
|
Autier, Philippe
|
|
2002
|
38 |
S1 |
p. S35-
1 p.
|
artikel
|
| 23 |
Session 6 S18. Is mammography screening for breast cancer really not justifiable?
|
Miller, Anthony B.
|
|
2002
|
38 |
S1 |
p. S21-
1 p.
|
artikel
|
| 24 |
Session 7 S23. Key issues in lung cancer chemoprevention trials of new agents
|
Lam, S.
|
|
2002
|
38 |
S1 |
p. S26-
1 p.
|
artikel
|
| 25 |
Session 2 S4. Low penetrance alleles and breast and colorectal cancer
|
Hunter, David
|
|
2002
|
38 |
S1 |
p. S6-
1 p.
|
artikel
|
| 26 |
Session 10 S33. Mass screening by flexible sigmoidoscopy
|
Cuzick, Jack
|
|
2002
|
38 |
S1 |
p. S36-
1 p.
|
artikel
|
| 27 |
Session 4 S11. Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs
|
Marks, Friedrich
|
|
2002
|
38 |
S1 |
p. S14-
1 p.
|
artikel
|
| 28 |
Session 3 S5. New approaches to cancer gene discovery
|
Weber, Barbara L.
|
|
2002
|
38 |
S1 |
p. S7-
1 p.
|
artikel
|
| 29 |
Session 4 S10. New cancer biomarkers deriving from the early detection research network of NCI/USA
|
Srivastava, Sudhir
|
|
2002
|
38 |
S1 |
p. S13-
1 p.
|
artikel
|
| 30 |
Session 6 S17. Political interpretation of scientific evidence: Case study of breast cancer screening policies around the world
|
Rennert, Gad
|
|
2002
|
38 |
S1 |
p. S20-
1 p.
|
artikel
|
| 31 |
Session 8 S24. Prevention of prostate cancer: The role of diet and nutrition
|
Schulman, C.
|
|
2002
|
38 |
S1 |
p. S27-
1 p.
|
artikel
|
| 32 |
Session 8 S27. Problems with PSA screening: A critical review
|
Schmid, Hans-Peter
|
|
2002
|
38 |
S1 |
p. S30-
1 p.
|
artikel
|
| 33 |
Session 8 S26. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria
|
Bartsch, Georg
|
|
2002
|
38 |
S1 |
p. S29-
1 p.
|
artikel
|
| 34 |
Session 5 S15. Tamoxifen and familial breast cancer
|
Powles, Trevor
|
|
2002
|
38 |
S1 |
p. S18-
1 p.
|
artikel
|
| 35 |
Session 3 S8. The biology of breast cancer in relation to efficient prevention
|
Howell, Anthony
|
|
2002
|
38 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 36 |
Session 3 S6. The cancer genome project
|
Wooster, Richard
|
|
2002
|
38 |
S1 |
p. S8-
1 p.
|
artikel
|
| 37 |
Session 1 S1. The prevention of breast cancer: Is genetics just diversionary?
|
Pike, Malcolm
|
|
2002
|
38 |
S1 |
p. S3-
1 p.
|
artikel
|
| 38 |
Session 4 S12. Transgenic and knockout mice: Their value in chemoprevention
|
Gusterson, Barry
|
|
2002
|
38 |
S1 |
p. S15-
1 p.
|
artikel
|
| 39 |
Session 6 S19. Validity of screening mammography trials
|
Feig, Stephen A.
|
|
2002
|
38 |
S1 |
p. S22-
1 p.
|
artikel
|
Tijdschrift beschrijving